文献速递肝病

纤维化-4指数可预测韩国成人全因、心血管及肝脏相关死亡率

Fibrosis-4 Index Predicts Long-Term All-Cause, Cardiovascular and Liver-Related Mortality in the Adult Korean Population.
PubMed 文献 · Clin Gastroenterol Hepatol · 2023-05-08

基于韩国国家健康与营养调查及死因登记数据,纳入46456名无病毒性肝炎的成人,中位随访8.6年。FIB-4≥2.67者较<2.67者全因死亡HR 1.64、心血管死亡HR 2.96、肝脏相关死亡HR 10.50,癌症死亡无显著关联。

要点

  • FIB-4≥2.67与全因死亡(HR 1.64)、心血管死亡(HR 2.96)、肝脏相关死亡(HR 10.50)相关。
  • FIB-4≥2.67与癌症死亡无显著关联。
  • 排除高酒精摄入者后结果不变。

核心结论

  • 在人群水平,FIB-4评估的肝纤维化与全因、心血管及肝脏相关累积死亡率升高相关。

研究设计与样本

  • 研究数据来自韩国国家健康与营养调查及韩国死因数据登记库。
  • 纳入年龄≥19岁、无乙型或丙型病毒性肝炎、肝硬化、任何癌症、卒中、心肌梗死、心绞痛或肾功能衰竭的成人。
  • 共46456人,中位随访8.6年(四分位距6.3-10.6年)。
  • 采用FIB-4评估 presumed 肝纤维化,使用多变量Cox回归计算风险比(HR)及95%CI,Kaplan-Meier法评估累积死亡率。

主要发现

  • Kaplan-Meier曲线显示,FIB-4≥2.67者(对比FIB-4<2.67者)累积全因、心血管、癌症及肝脏相关死亡率更高。
  • 完全调整模型中,FIB-4≥2.67与全因死亡相关(HR 1.64;95%CI 1.23-2.18)。
  • FIB-4≥2.67与心血管死亡相关(HR 2.96;95%CI 1.60-5.46)。
  • FIB-4≥2.67与肝脏相关死亡相关(HR 10.50;95%CI 4.70-23.44)。
  • FIB-4≥2.67与癌症死亡无显著关联。

关键数值与推荐

  • FIB-4≥2.67定义为 presumed advanced hepatic fibrosis。
  • 全因死亡HR 1.64(95%CI 1.23-2.18)。
  • 心血管死亡HR 2.96(95%CI 1.60-5.46)。
  • 肝脏相关死亡HR 10.50(95%CI 4.70-23.44)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Associations between hepatic fibrosis and mortality remain to be fully elucidated in large population-based studies. This study aimed to evaluate the associations of the fibrosis-4 index (FIB-4) with all-cause, cardiovascular, cancer, and liver-related mortality in the adult Korean population without viral hepatitis. METHODS: Baseline data were retrieved from the Korea National Health and Nutrition Examination Survey, and mortality data were retrieved from the Korean Cause of Death data registry. Adults (age, ≥19 y) without viral hepatitis B or C, liver cirrhosis, any cancer, stroke, myocardial infarction, angina pectoris, or renal failure at baseline were eligible. Presumed hepatic fibrosis was evaluated with FIB-4. Hazard ratios (HRs) and 95% CIs were calculated using multivariable Cox regression analysis, and Kaplan-Meier estimates of the cumulative mortality were evaluated. RESULTS: There were 46,456 individuals with a median follow-up period of 8.6 years (interquartile range, 6.3-10.6 y). Kaplan-Meier curves for cumulative mortality showed that participants with a FIB-4 of ≥2.67 (vs FIB-4, <2.67) had higher cumulative all-cause, cardiovascular, cancer, and liver-related mortality. In the fully adjusted model, Cox regression analysis revealed that presumed advanced hepatic fibrosis (FIB-4, ≥2.67) remained associated with all-cause mortality (HR, 1.64; 95% CI, 1.23-2.18), cardiovascular mortality (HR, 2.96; 95% CI, 1.60-5.46), and liver-related mortality (HR, 10.50; 95% CI, 4.70-23.44), but not cancer mortality, after adjusting for confounders including central obesity and insulin resistance. Excluding participants with an estimated alcohol intake of 30 grams or more for men and 20 grams or more for women did not affect the results. CONCLUSIONS: At the population level, liver fibrosis estimated by FIB-4 was associated with increased cumulative all-cause, cardiovascular, and liver-related mortality.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Seo YG, Polyzos SA, Park KH, et al. Fibrosis-4 Index Predicts Long-Term All-Cause, Cardiovascular and Liver-Related Mortality in the Adult Korean Population. Clin Gastroenterol Hepatol. 2023. PMID: 37164111. doi:10.1016/j.cgh.2023.04.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。